Nifty
:
25044.35
Sensex
:
82055.11
72.45 (0.29%)
158.32 (0.19%)
Nifty
Sensex
:
:
25044.35
82055.11
72.45 (0.29%)
158.32 (0.19%)

Laurus Labs Ltd.

Pharmaceuticals & Drugs - API

Rating :
61/99

BSE: 540222 | NSE: LAURUSLABS

NSE BSE
669.55
24-Jun-2025
  • Open
  • High
  • Low
  • Previous Close
  •  672
  •  673.35
  •  664.15
  •  666.30
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1034160
  •  692879649.55
  •  683
  •  414

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 36,121.17
  • 100.81
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 38,670.04
  • 0.18%
  • 8.12

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 27.62%
  • 8.26%
  • 23.64%
  • FII
  • DII
  • Others
  • 25.51%
  • 10.51%
  • 4.46%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.07
  • 2.90
  • -2.76

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.29
  • -7.41
  • -7.90

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.20
  • -18.47
  • -23.56

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 32.81
  • 34.49
  • 60.32

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.79
  • 7.34
  • 6.07

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.14
  • 22.65
  • 24.98

Earnings Forecasts:

(Updated: 06-06-2025)
Description
2024
2025
2026
2027
Adj EPS
2.98
6.65
10.71
15.49
P/E Ratio
224.68
100.68
62.52
43.22
Revenue
5002
5554
6401
7504
EBITDA
749
1055
1410
1808
Net Income
161
358
577
835
ROA
2
4
6
8
P/B Ratio
8.58
8.07
7.25
6.32
ROE
3.94
8.35
12.01
15.13
FCFF
-181
-242
111
252
FCFF Yield
-0.51
-0.68
0.31
0.71
Net Debt
2436
2549
2653
2613
BVPS
78.06
82.94
92.29
105.99

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Net Sales
1,720.30
1,439.67
19.49%
1,415.05
1,194.92
18.42%
1,223.70
1,224.45
-0.06%
1,194.91
1,181.79
1.11%
Expenses
1,299.70
1,198.18
8.47%
1,129.90
1,013.50
11.48%
1,045.37
1,036.58
0.85%
1,023.71
1,015.07
0.85%
EBITDA
420.60
241.49
74.17%
285.15
181.42
57.18%
178.33
187.87
-5.08%
171.20
166.72
2.69%
EBIDTM
24.45%
16.77%
20.15%
15.18%
14.57%
15.34%
14.33%
14.11%
Other Income
58.57
18.53
216.08%
9.42
2.43
287.65%
4.60
1.78
158.43%
2.51
3.60
-30.28%
Interest
56.40
50.50
11.68%
57.80
50.82
13.73%
52.61
42.39
24.11%
49.19
39.19
25.52%
Depreciation
110.43
102.25
8.00%
106.09
98.41
7.80%
107.51
93.37
15.14%
106.06
90.55
17.13%
PBT
312.34
107.27
191.17%
130.68
34.62
277.47%
22.81
53.89
-57.67%
18.46
40.58
-54.51%
Tax
78.47
31.95
145.60%
40.07
9.45
324.02%
5.09
14.57
-65.07%
6.25
12.18
-48.69%
PAT
233.87
75.32
210.50%
90.61
25.17
259.99%
17.72
39.32
-54.93%
12.21
28.40
-57.01%
PATM
13.59%
5.23%
6.40%
2.11%
1.45%
3.21%
1.02%
2.40%
EPS
4.33
1.40
209.29%
1.71
0.43
297.67%
0.37
0.69
-46.38%
0.23
0.46
-50.00%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
-
5,553.96
5,040.83
6,040.55
4,935.57
4,813.51
2,831.72
2,291.92
2,056.17
1,904.65
1,777.58
Net Sales Growth
-
10.18%
-16.55%
22.39%
2.54%
69.99%
23.55%
11.47%
7.96%
7.15%
 
Cost Of Goods Sold
-
2,395.08
2,374.35
2,729.67
2,133.89
2,107.62
1,382.88
1,224.80
1,056.02
989.29
1,000.15
Gross Profit
-
3,158.88
2,666.48
3,310.88
2,801.68
2,705.89
1,448.84
1,067.12
1,000.15
915.36
777.43
GP Margin
-
56.88%
52.90%
54.81%
56.77%
56.21%
51.16%
46.56%
48.64%
48.06%
43.74%
Total Expenditure
-
4,498.68
4,263.33
4,448.36
3,513.14
3,262.83
2,267.17
1,935.93
1,642.85
1,497.01
1,415.38
Power & Fuel Cost
-
323.40
338.15
324.10
204.47
157.75
136.77
109.37
94.21
66.27
57.95
% Of Sales
-
5.82%
6.71%
5.37%
4.14%
3.28%
4.83%
4.77%
4.58%
3.48%
3.26%
Employee Cost
-
676.44
614.85
557.43
469.55
397.04
320.77
276.33
238.14
204.73
175.46
% Of Sales
-
12.18%
12.20%
9.23%
9.51%
8.25%
11.33%
12.06%
11.58%
10.75%
9.87%
Manufacturing Exp.
-
648.97
611.80
522.90
441.18
364.78
239.50
178.96
150.78
139.47
106.97
% Of Sales
-
11.68%
12.14%
8.66%
8.94%
7.58%
8.46%
7.81%
7.33%
7.32%
6.02%
General & Admin Exp.
-
201.69
157.89
151.15
146.49
133.28
114.23
97.48
73.17
65.42
49.09
% Of Sales
-
3.63%
3.13%
2.50%
2.97%
2.77%
4.03%
4.25%
3.56%
3.43%
2.76%
Selling & Distn. Exp.
-
170.95
134.49
116.14
101.98
91.65
61.53
31.96
24.09
22.65
16.49
% Of Sales
-
3.08%
2.67%
1.92%
2.07%
1.90%
2.17%
1.39%
1.17%
1.19%
0.93%
Miscellaneous Exp.
-
82.15
31.80
46.97
15.58
10.71
11.49
17.03
6.44
9.18
16.49
% Of Sales
-
1.48%
0.63%
0.78%
0.32%
0.22%
0.41%
0.74%
0.31%
0.48%
0.52%
EBITDA
-
1,055.28
777.50
1,592.19
1,422.43
1,550.68
564.55
355.99
413.32
407.64
362.20
EBITDA Margin
-
19.00%
15.42%
26.36%
28.82%
32.22%
19.94%
15.53%
20.10%
21.40%
20.38%
Other Income
-
75.10
26.34
6.00
15.30
23.66
5.92
16.15
29.19
33.44
4.36
Interest
-
216.00
182.90
165.17
102.39
68.16
89.59
88.19
79.64
99.90
111.11
Depreciation
-
430.09
384.58
324.08
251.49
205.07
187.27
164.19
125.45
105.98
86.41
PBT
-
484.29
236.36
1,108.94
1,083.85
1,301.11
293.61
119.75
237.42
235.19
169.04
Tax
-
129.88
68.15
312.30
251.42
317.29
38.34
25.99
69.81
43.86
34.90
Tax Rate
-
26.82%
28.83%
28.16%
23.20%
24.39%
13.06%
21.70%
29.40%
18.65%
20.65%
PAT
-
354.39
166.49
793.37
827.72
983.58
255.27
93.76
167.61
191.33
134.14
PAT before Minority Interest
-
354.41
168.21
796.64
832.43
983.82
255.27
93.76
167.61
191.33
134.14
Minority Interest
-
-0.02
-1.72
-3.27
-4.71
-0.24
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
6.38%
3.30%
13.13%
16.77%
20.43%
9.01%
4.09%
8.15%
10.05%
7.55%
PAT Growth
-
112.86%
-79.01%
-4.15%
-15.85%
285.31%
172.26%
-44.06%
-12.40%
42.63%
 
EPS
-
6.57
3.09
14.71
15.35
18.24
4.73
1.74
3.11
3.55
2.49

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
4,472.56
4,110.95
4,037.53
3,351.19
2,597.55
1,769.77
1,558.41
1,482.64
1,330.45
856.80
Share Capital
107.85
107.79
107.73
107.47
107.32
106.91
106.44
106.03
105.76
82.38
Total Reserves
4,338.66
3,981.69
3,917.72
3,234.55
2,485.31
1,658.23
1,446.60
1,370.75
1,218.84
771.47
Non-Current Liabilities
1,193.33
1,159.18
1,179.48
927.98
692.84
214.24
295.49
174.30
132.34
428.11
Secured Loans
645.58
798.23
761.42
596.34
429.16
165.02
258.71
141.66
124.56
353.61
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
106.13
Long Term Provisions
106.09
93.47
81.47
72.67
63.19
45.85
30.05
20.84
14.59
6.77
Current Liabilities
3,539.72
3,112.28
2,432.26
2,681.01
2,457.15
1,692.38
1,423.90
1,306.89
1,120.75
883.75
Trade Payables
958.49
1,051.24
710.65
876.37
1,178.69
615.63
488.31
312.33
263.10
247.61
Other Current Liabilities
779.69
610.73
640.75
839.73
367.25
261.47
244.50
231.26
199.11
141.05
Short Term Borrowings
1,715.00
1,389.29
995.77
910.72
886.12
790.51
684.21
758.52
644.17
481.42
Short Term Provisions
86.54
61.02
85.09
54.19
25.09
24.77
6.89
4.78
14.37
13.66
Total Liabilities
9,335.57
8,387.03
7,660.40
6,968.04
5,750.69
3,676.39
3,277.80
2,963.83
2,583.54
2,168.66
Net Block
4,123.22
3,890.01
3,408.62
2,652.47
2,170.62
1,726.34
1,629.07
1,480.80
1,229.93
1,021.03
Gross Block
6,284.33
5,652.20
4,794.82
3,750.20
3,027.97
2,387.71
2,105.42
1,793.75
1,418.58
1,106.33
Accumulated Depreciation
2,161.11
1,762.19
1,386.20
1,097.73
857.35
661.37
476.35
312.95
188.65
85.30
Non Current Assets
5,003.25
4,552.06
4,198.72
3,623.43
2,675.83
1,864.33
1,814.84
1,716.23
1,443.71
1,165.92
Capital Work in Progress
458.36
422.84
550.78
813.22
362.17
67.18
109.63
163.18
143.26
69.60
Non Current Investment
233.26
123.98
49.90
30.81
3.41
3.41
3.40
3.40
3.40
7.04
Long Term Loans & Adv.
163.40
83.50
160.58
84.11
108.52
40.80
25.58
29.36
25.95
29.22
Other Non Current Assets
25.01
31.73
28.84
42.82
31.11
26.60
47.16
39.50
41.17
39.03
Current Assets
4,332.32
3,834.97
3,461.68
3,344.61
3,074.86
1,812.06
1,462.96
1,247.59
1,139.82
1,002.73
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
1,936.54
1,845.41
1,684.81
1,760.30
1,575.45
905.22
681.94
584.78
509.05
487.09
Sundry Debtors
2,007.16
1,662.92
1,580.44
1,354.18
1,306.06
791.42
709.94
570.59
567.61
444.86
Cash & Bank
144.21
141.65
48.46
75.94
48.46
1.74
3.02
3.06
4.09
28.77
Other Current Assets
244.41
37.83
39.07
19.71
144.89
113.68
68.06
89.16
59.08
42.00
Short Term Loans & Adv.
207.06
147.16
108.90
134.48
88.39
61.91
35.22
58.63
25.01
23.86
Net Current Assets
792.60
722.69
1,029.42
663.60
617.71
119.68
39.05
-59.30
19.07
118.98
Total Assets
9,335.57
8,387.03
7,660.40
6,968.04
5,750.69
3,676.39
3,277.80
2,963.82
2,583.53
2,168.65

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
601.65
665.69
993.90
911.10
733.00
347.42
297.66
342.49
331.99
181.97
PBT
484.29
236.36
1,108.94
1,083.85
1,301.11
293.61
119.75
237.42
235.19
169.04
Adjustment
629.50
562.92
485.71
351.13
254.45
293.21
247.69
216.47
199.38
200.57
Changes in Working Capital
-374.60
-29.02
-315.26
-341.61
-594.06
-199.76
-44.46
-49.48
-52.45
-154.37
Cash after chg. in Working capital
739.19
770.26
1,279.39
1,093.37
961.50
387.06
322.99
404.41
382.12
215.23
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-137.54
-104.57
-285.49
-182.27
-228.50
-39.64
-25.32
-61.91
-50.13
-33.26
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-681.72
-822.42
-996.06
-914.34
-940.99
-221.13
-252.88
-384.15
-288.67
-312.20
Net Fixed Assets
-360.50
-288.19
-567.41
-1,025.56
-572.84
-236.25
-254.84
-394.43
-354.15
-76.75
Net Investments
-105.35
-250.75
-22.40
-42.83
-260.57
-0.01
-6.57
-1.22
-24.40
-7.01
Others
-215.87
-283.48
-406.25
154.05
-107.58
15.13
8.53
11.50
89.88
-228.44
Cash from Financing Activity
39.28
249.83
-26.64
30.26
254.70
-127.66
-44.77
42.24
-53.61
103.32
Net Cash Inflow / Outflow
-40.79
93.10
-28.80
27.02
46.71
-1.37
0.02
0.59
-10.30
-26.91
Opening Cash & Equivalents
138.94
45.67
75.35
48.46
1.69
2.97
3.00
2.42
12.81
39.53
Closing Cash & Equivalent
99.54
138.94
45.67
75.35
48.46
1.69
2.97
3.00
2.42
12.81

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
82.46
75.88
74.73
62.19
48.32
33.02
29.18
27.86
25.05
99.86
ROA
4.00%
2.10%
10.89%
13.09%
20.87%
7.34%
3.00%
6.04%
8.05%
6.61%
ROE
8.30%
4.15%
21.63%
28.05%
45.15%
15.39%
6.19%
11.97%
18.12%
18.65%
ROCE
10.16%
6.64%
22.97%
25.97%
39.82%
14.14%
8.22%
13.68%
16.52%
16.35%
Fixed Asset Turnover
0.93
0.97
1.41
1.46
1.78
1.26
1.18
1.29
1.53
1.73
Receivable days
120.60
117.42
88.66
98.37
79.52
96.76
101.97
100.40
95.66
73.56
Inventory Days
124.27
127.81
104.09
123.34
94.05
102.29
100.87
96.48
94.12
97.00
Payable days
153.14
135.42
106.10
175.76
155.37
145.69
72.80
61.13
59.14
58.52
Cash Conversion Cycle
91.73
109.81
86.64
45.95
18.21
53.36
130.03
135.75
130.64
112.05
Total Debt/Equity
0.61
0.61
0.49
0.52
0.56
0.60
0.67
0.66
0.64
1.20
Interest Cover
3.24
2.29
7.71
11.59
20.09
4.28
2.36
3.98
3.35
2.52

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Laurus Labs gets EIR for API manufacturing facility in Andhra Pradesh
    15th Apr 2025, 14:18 PM

    The USFDA inspection was conducted from January 27, 2025 to January 31, 2025

    Read More
  • Laurus Labs gets nod to acquire up to 26% stake in Kurnool Renewables
    28th Mar 2025, 16:40 PM

    The investment by the company is expected to be completed within a period of 1 year in three stages

    Read More
  • Laurus Labs acquires equity shares in KRKA
    17th Mar 2025, 11:22 AM

    The company has invested Rs 83.30 crore

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.